Pisgah Laboratories Expands Transylvania County, North Carolina, Operations
08/01/2022
The investment will add sterile injectables and liquid filling operations with a new pilot manufacturing facility, quality control laboratory, warehousing, and microbiological laboratories. The expansion also includes a commitment to develop a life sciences training collaborative with local and regional colleges, universities, and Transylvania County manufacturers.
“We are excited to begin this expansion of Pisgah Labs,” said Dani Bailey, Site Manager of Pisgah Labs, Inc. “We are grateful for the support from North Carolina and Transylvania County. Our parent company, Ipca Laboratories Limited, is making a large investment in Pisgah’s future. Carving a space in the highly competitive pharmaceutical market is not an easy task, but we welcome the challenge and intend to see many years of company growth, job creation and education opportunities for Pisgah Labs and western North Carolina.”
A performance-based grant of $50,000 from the One North Carolina Fund will help with Pisgah Labs’ expansion. The One NC Fund provides financial assistance to local governments to help attract economic investment and to create jobs. Companies receive no money upfront and must meet job creation and capital investment targets to qualify for payment. All One NC grants require matching participation from local governments and any award is contingent upon that condition being met.
“Pisgah Labs shares our economic development strategy which prioritizes creative partnerships with an emphasis on workforce training,” said N.C. Commerce Secretary Machelle Baker Sanders. “As a leader in pharmaceutical manufacturing and with our robust network of research institutions, North Carolina has the right formula to support thriving life sciences companies.”
With roots in x-ray film dye and agrochemicals, Pisgah Labs was founded in North Carolina in 1981. The company received its first FDA approval to manufacture active pharmaceutical ingredients in 2002 before exclusively developing pharmaceuticals in 2005. Pisgah holds 31 patents and manufactures the active ingredients for pain medicines and the treatment of disorders and diseases, such as Alzheimer’s and fibromyalgia.
In addition to the N.C. Department of Commerce and the Economic Development Partnership of North Carolina (EDPNC), other key partners in the project include the North Carolina General Assembly, North Carolina Biotechnology Center, North Carolina Community College System, Blue Ridge Community College, Transylvania County and the Transylvania Economic Alliance.
Project Announcements
Kimberly-Clark Expands Aiken County, South Carolina, Distribution Operations
05/04/2025
Aerowerks Plans Gaffney, South Carolina, Manufacturing Operations
05/04/2025
Sweden-Based Troax Group Plans Portland, Tennessee, Manufacturing Operations
05/04/2025
Kimberly-Clark Corporation Plans Warren, Ohio, Manufacturing Operations
05/04/2025
Denmark-Based Novonesis Expands Salem, Virginia, Production Operations
05/04/2025
Polyvlies USA Expands Winston-Salem, North Carolina, Manufacturing Operations
05/04/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
The Location Economics of Advanced Nuclear
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Is It Time to Start Planning for Quantum Data Centers?
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024